Patent ID: 11958830
Assignee: WESTLAKE PHARMACEUTICALS (HANGZHOU) CO., LTD.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 15:
16. The compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt according to claim 15, wherein R1, for each occurrence, is independently selected from halogen, cyano, C1-C4 alkyl, C1-C4 alkoxy, —C(═O)(C1-C4 alkyl), —C(═O)NRpRq, —NRpRq, and —ORs; wherein:
the C1-C4 alkyl and the C1-C4 alkoxy of R1 and the C1-C4 alkyl of —C(═O)(C1-C4 alkyl) are each optionally substituted with 1 to 3 groups selected from halogen, cyano, and —ORs;
Rp and Rq, for each occurrence, are each independently selected from hydrogen and C1-C2 alkyl; and
Rs, for each occurrence, is independently selected from hydrogen and C1-C2 alkyl.